Avience Biomedicals Sets the Stage for IPO: Key Details on GMP, Price Band, and More Revealed!
The IPO of Avience Biomedicals, a Noida-based molecular diagnostics manufacturer, is set to open for subscription on June 22, 2026, with a pricing band of Rs 196 to Rs 208 per share. The issue, which will close on June 22, has a total size of Rs 30.24 crore and involves a fresh issue of 14,53,800 shares with no offer-for-sale component, meaning that all proceeds will benefit the company directly. Allotment is expected on June 23, and the listing on the NSE SME platform is scheduled for June 25. This IPO represents an important milestone for Avience Biomedicals, solidifying its position in the burgeoning molecular diagnostics market in India.
Ahead of its opening, the grey market premium (GMP) for the Avience IPO stood at 36%, indicating a strong pre-listing demand that suggests investors anticipate a healthy listing-day gain. The unofficial market price is estimated to be around Rs 283 per share against the upper end of the issue band, highlighting a premium of about Rs 75 per share. This positive sentiment contrasts sharply with the muted activity noted in several other SME IPOs launching this week, reinforcing the strong investor interest in Avience Biomedicals.
For Indian investors, Avience’s IPO presents a compelling opportunity into the healthcare sector, particularly in diagnostics, which has shown resilience and potential for growth. The allocation strategy supports a balanced participation from different investor profiles, with 49.83% designated for qualified institutional buyers and significant shares for retail (35.08%) and non-institutional investors (15.09%). Given the company’s promising financial trajectory, with significant revenue growth and focused plans for expansion, this IPO could align well with the long-term investment strategies of interested investors and highlight the growing importance of biotechnology and diagnostic solutions in India’s economy.
Source: The Economic Times
(Expert Note: This report was prepared by the Wealthova IPO team.)